Real Estate / REIT - Healthcare FacilitiesASX
$0.71
-0.01 (-1.39%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 100% · confianza 20%
FCF escenarios
weak_data · normalized FCF n/d · quality 6.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
36/100
D
Piotroski
0/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$391M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-11.3%
↓Gross Margin
68.1%
↑Debt/Equity
0.57
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+29.4%
FCF CAGR
-8.1%
FCF margin
34.5%
FCF / Net income
-0.21x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $53.0M · net income $-88.8M · FCF $18.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $53.0M | $53.0M | $64.0M | $40.2M | $24.5M |
| Net Income | $-88.8M | $-88.8M | $6.9M | $20.2M | $49.6M |
| EBITDA | $-64.1M | $-64.1M | $34.7M | $33.8M | $52.9M |
| EPS | -0.16 | -0.16 | 0.01 | 0.05 | 0.15 |
| Gross Margin | 68.1% | 68.1% | 73.4% | 60.4% | 66.7% |
| Operating Margin | 62.5% | 62.5% | 68.9% | 55.0% | 55.9% |
| Net Margin | -167.5% | -167.5% | 10.8% | 50.2% | 202.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.57 | 0.57 | 0.53 | 0.74 | 0.03 |
| Current Ratio | 0.14 | 0.14 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $18.3M | $18.3M | $6.4M | $22.7M | $23.6M |
| Returns | |||||
| ROE | -11.3% | -11.3% | 0.8% | 2.1% | 7.6% |
| Valuation | |||||
| P/E | — | — | 88.11 | 24.72 | 9.63 |
| EV/EBITDA | — | — | 30.85 | 35.38 | 9.40 |
| P/B | 0.50 | 0.50 | 0.67 | 0.53 | 0.73 |
| Growth & Yield | |||||
| Revenue Growth | -17.2% | -17.2% | 59.2% | 64.3% | — |
| EPS Growth | -1411.5% | -1411.5% | -77.6% | -63.7% | — |
| Dividend Yield | 11.4% | 11.4% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+2.4%
Start / end P/E
n/dx → n/dx
EPS bridge
0.01 → -0.16
Residual
-9.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.